Who has invested in Nine Square Therapeutics?

Apple Tree Partners are named among the investors backing Nine Square Therapeutics.

Nine Square Therapeutics Funding: $4.5M Raised, Series A

Nine Square Therapeutics funding overview

Nine Square Therapeutics is based in South San Francisco, California. Nine Square Therapeutics has raised $4.5M in total disclosed funding. That places its disclosed total in the $1M–$25M range. Its most recent disclosed round is a Series A announced in September 2023. The round record for Nine Square Therapeutics runs through 2023; nothing later has been disclosed. Investors on record include Apple Tree Partners.

Nine Square Therapeutics at a glance

Total raised: $4.5M
Latest round: Series A
Latest round date: September 2023
Headquarters: South San Francisco, California
Notable investors: Apple Tree Partners

Frequently asked about Nine Square Therapeutics funding

How much has Nine Square Therapeutics raised?: Nine Square Therapeutics has raised $4.5M in total disclosed funding across the rounds on record.
Who has invested in Nine Square Therapeutics?: Apple Tree Partners are named among the investors backing Nine Square Therapeutics.
What was the latest Nine Square Therapeutics funding round?: The most recent disclosed round is a Series A, announced in September 2023.
Where is Nine Square Therapeutics based?: Nine Square Therapeutics is based in South San Francisco, California.
When did Nine Square Therapeutics last raise?: The last disclosed Nine Square Therapeutics round closed in September 2023 at Series A.

Every Nine Square Therapeutics figure above comes from filings and announced rounds in the StartupFundraising company database and is revised as new rounds are recorded. The lists below compare companies in South San Francisco at a similar stage.

Nine Square Therapeutics Funding: $4.5M Raised, Series A

Nine Square Therapeutics funding overview

Nine Square Therapeutics at a glance

Frequently asked about Nine Square Therapeutics funding

Companies related to Nine Square Therapeutics (31)

Browse related funding lists (4)